Results for “Pancreatic” 12 results

All 12 Health 9 US Politics 2 Society 1
Pancreatic Cancer Pill Reshapes U.S. Oncology Spending Debate
Health 08 Jun 2026
Pancreatic Cancer Pill Reshapes U.S. Oncology Spending Debate
A new pancreatic cancer pill, Daraxonrasib, is reshaping U.S. oncology spending debates, offering a targeted therapy and challeng…
Pancreatic Cancer Drug Approval Reshapes U.S. Oncology Funding
US Politics 27 Aug 2026
Pancreatic Cancer Drug Approval Reshapes U.S. Oncology Funding
Daraxonrasib's FDA clearance may redirect NIH grants and private research dollars.
Type 1 Diabetes Drug Delay Puts U.S. Insurers on Defense
Health 24 Jun 2026
Type 1 Diabetes Drug Delay Puts U.S. Insurers on Defense
European immunotherapy approvals for Type 1 diabetes are prompting U.S. insurers to reassess coverage of preventative treatments …
Wegovy Pill Form Puts U.S. Oral GLP-1 Market on Notice
Health 12 Jun 2026
Wegovy Pill Form Puts U.S. Oral GLP-1 Market on Notice
Novo Nordisk's Wegovy oral tablet formulation of semaglutide intensifies competition in the U.S. GLP-1 weight-loss drug market, s…
Personalized Cancer Vaccine Trial Reshapes U.S. Oncology Race
Society 20 Aug 2026
Personalized Cancer Vaccine Trial Reshapes U.S. Oncology Race
Silicon Valley biotech firms eye licensing rights as NIH weighs funding priorities
mRNA Cancer Vaccine Trial Stirs U.S. Biotech Investment Rush
Health 01 Sep 2026
mRNA Cancer Vaccine Trial Stirs U.S. Biotech Investment Rush
Recurrence data prompts Wall Street to reassess oncology pipeline bets.
Morning-After Pill Access Shift Tests U.S. Coverage Debate
Health 02 Aug 2026
Morning-After Pill Access Shift Tests U.S. Coverage Debate
Federal data gaps leave lawmakers split on expanding no-cost contraception mandates
Thermostable Vaccines Reshape U.S. Cold Chain Spending Bets
Health 06 Aug 2026
Thermostable Vaccines Reshape U.S. Cold Chain Spending Bets
Room-temperature stability breakthrough pressures federal logistics contracts
FDA's New Weight-Loss Pill Reshapes U.S. Obesity Drug Market
Health 14 Aug 2026
FDA's New Weight-Loss Pill Reshapes U.S. Obesity Drug Market
Eli Lilly's oral GLP-1 entry could pressure insurers and rivals as demand surges
FDA Weighs Urine Cancer Test That Rivals Invasive Methods
Health 03 Sep 2026
FDA Weighs Urine Cancer Test That Rivals Invasive Methods
New bladder cancer screen detects 90% of cases, drawing U.S. regulatory scrutiny
NASA's New Telescope Reshapes U.S. Science Funding Calculus
US Politics 31 Aug 2026
NASA's New Telescope Reshapes U.S. Science Funding Calculus
Multi-year universe mapping mission revives debate over federal research priorities
Pig Kidney Milestone Shifts U.S. Transplant Donor Debate
Health Yesterday
Pig Kidney Milestone Shifts U.S. Transplant Donor Debate
Record 271-day survival renews pressure on Congress to fund xenotransplant research
Topics: NHS Policy Ukraine War NHS Net Zero Starmer Zero League Artificial Intelligence Ukraine Senate Russia Champions Champions League Mental Health Renewable Energy Final Bill Grid Block Target Energy Security Council